Trials / Active Not Recruiting
Active Not RecruitingNCT06790862
A Trial of SHR0302Base in Patients With Vitiligo
A Multicenter, Randomized, Double-blind, Parallel, Excipient-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of SHR0302Base in Subjects With Nonsegmental Vitiligo
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 155 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of SHR0302Base in participants with nonsegmental vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302Base gel | SHR0302Base gel. |
| DRUG | SHR0302Base gel placebo | SHR0302Base gel placebo. |
Timeline
- Start date
- 2025-02-13
- Primary completion
- 2026-03-03
- Completion
- 2026-04-01
- First posted
- 2025-01-24
- Last updated
- 2026-01-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06790862. Inclusion in this directory is not an endorsement.